Nanoparticles (NPs) are of similar size to typical cellular components and proteins, and can
efficiently intrude living cells. A detailed understanding of the involved processes at the …

Engineered nanomaterials are known to enter human cells, often via active endocytosis.
Mechanistic details of the interactions between nanoparticles (NPs) with cells are still not …

Nanoparticles (NP) are attractive options for the therapeutic delivery of active
pharmaceutical drugs, proteins and nucleic acids into cells, tissues and organs. Research …

Nanoparticle uptake by cells has been studied for applications both in nanomedicine and in
nanosafety. While the majority of studies have focused on the biological mechanisms …

Cell membrane coated nanoparticles (NPs) have recently been recognized as attractive
nanomedical tools because of their unique properties such as immune escape, long blood …

Many applications of nanomedicines depend on the therapeutic gaining access to the
interior of cells. As most proteins and nanoparticles are taken up by endocytosis …

Nanomaterials promise to improve disease diagnosis and treatment by enhancing the
delivery of drugs, genes, biomolecules and imaging agents to specific subcellular targets. In …

Over the past decade, nanoparticles (NPs) have been increasingly developed in various
biomedical applications such as cell tracking, biosensing, contrast imaging, targeted drug …

The complexity of nanoscale interactions between biomaterials and cells has limited the
realization of the ultimate vision of nanotechnology in diagnostics and therapeutics. As such …

Endocytosis is a fundamental process in which eukaryotic cells internalise molecules and
macromolecules via deformation of the membrane and generation of membrane-bound …